Strides Pharma gets USFDA nod to market generic headache drug
Posted by
www.biotecnika.org
The product, which will be marketed by Singapore-based Strides Pharma
Inc in the US market, is a generic version of Teva's Fioricet with
Codeine capsules, it added.
https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/strides-pharma-gets-usfda-nod-to-market-generic-headache-drug/articleshow/76869302.cms
Subscribe to:
Post Comments (Atom)
Post a Comment